Biology-oriented synthesis - PubMed (original) (raw)
Review
. 2011 Nov 11;50(46):10800-26.
doi: 10.1002/anie.201007004. Epub 2011 Oct 28.
Affiliations
- PMID: 22038946
- DOI: 10.1002/anie.201007004
Review
Biology-oriented synthesis
Stefan Wetzel et al. Angew Chem Int Ed Engl. 2011.
Abstract
Which compound classes are best suited as probes and tools for chemical biology research and as inspiration for medicinal chemistry programs? Chemical space is enormously large and cannot be exploited conclusively by means of synthesis efforts. Methods are required that allow one to identify and map the biologically relevant subspaces of vast chemical space, and serve as hypothesis-generating tools for inspiring synthesis programs. Biology-oriented synthesis builds on structural conservatism in the evolution of proteins and natural products. It employs a hierarchical classification of bioactive compounds according to structural relationships and type of bioactivity, and selects the scaffolds of bioactive molecule classes as starting points for the synthesis of compound collections with focused diversity. Navigation in chemical space is facilitated by Scaffold Hunter, an intuitively accessible and highly interactive software. Small molecules synthesized according to BIOS are enriched in bioactivity. They facilitate the analysis of complex biological phenomena by means of acute perturbation and may serve as novel starting points to inspire drug discovery programs.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
- Bioactivity-guided navigation of chemical space.
Bon RS, Waldmann H. Bon RS, et al. Acc Chem Res. 2010 Aug 17;43(8):1103-14. doi: 10.1021/ar100014h. Acc Chem Res. 2010. PMID: 20481515 - Charting, navigating, and populating natural product chemical space for drug discovery.
Lachance H, Wetzel S, Kumar K, Waldmann H. Lachance H, et al. J Med Chem. 2012 Jul 12;55(13):5989-6001. doi: 10.1021/jm300288g. Epub 2012 May 11. J Med Chem. 2012. PMID: 22537178 Review. - Biology-oriented synthesis: harnessing the power of evolution.
van Hattum H, Waldmann H. van Hattum H, et al. J Am Chem Soc. 2014 Aug 27;136(34):11853-9. doi: 10.1021/ja505861d. Epub 2014 Aug 5. J Am Chem Soc. 2014. PMID: 25074019 - Principles, implementation, and application of biology-oriented synthesis (BIOS).
Wilk W, Zimmermann TJ, Kaiser M, Waldmann H. Wilk W, et al. Biol Chem. 2010 May;391(5):491-7. doi: 10.1515/BC.2010.013. Biol Chem. 2010. PMID: 20030592 Review. - Expanding the medicinally relevant chemical space with compound libraries.
López-Vallejo F, Giulianotti MA, Houghten RA, Medina-Franco JL. López-Vallejo F, et al. Drug Discov Today. 2012 Jul;17(13-14):718-26. doi: 10.1016/j.drudis.2012.04.001. Epub 2012 Apr 10. Drug Discov Today. 2012. PMID: 22515962 Review.
Cited by
- Divergent synthesis and identification of the cellular targets of deoxyelephantopins.
Lagoutte R, Serba C, Abegg D, Hoch DG, Adibekian A, Winssinger N. Lagoutte R, et al. Nat Commun. 2016 Aug 19;7:12470. doi: 10.1038/ncomms12470. Nat Commun. 2016. PMID: 27539788 Free PMC article. - Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein-Ligand Interactions and High Selectivity.
Collie GW, Clark MA, Keefe AD, Madin A, Read JA, Rivers EL, Zhang Y. Collie GW, et al. J Med Chem. 2024 Jan 25;67(2):864-884. doi: 10.1021/acs.jmedchem.3c01861. Epub 2024 Jan 10. J Med Chem. 2024. PMID: 38197367 Free PMC article. Review. - Engineering of fluorescent or photoactive Trojan probes for detection and eradication of β-Amyloids.
Aziz AA, Siddiqui RA, Amtul Z. Aziz AA, et al. Drug Deliv. 2020 Dec;27(1):917-926. doi: 10.1080/10717544.2020.1785048. Drug Deliv. 2020. PMID: 32597244 Free PMC article. - Nature-inspired remodeling of (aza)indoles to meta-aminoaryl nicotinates for late-stage conjugation of vitamin B3 to (hetero)arylamines.
Varun BV, Vaithegi K, Yi S, Park SB. Varun BV, et al. Nat Commun. 2020 Dec 9;11(1):6308. doi: 10.1038/s41467-020-19610-2. Nat Commun. 2020. PMID: 33298909 Free PMC article. - Discovery of a tetrazolyl β-carboline with in vitro and in vivo osteoprotective activity under estrogen-deficient conditions.
Karvande A, Khan S, Khan I, Singh D, Khedgikar V, Kushwaha P, Ahmad N, Kothari P, Dhasmana A, Kant R, Trivedi R, Chauhan PMS. Karvande A, et al. Medchemcomm. 2018 Jun 12;9(7):1213-1225. doi: 10.1039/c8md00109j. eCollection 2018 Jul 1. Medchemcomm. 2018. PMID: 30109010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources